Global Menopausal Medications Supply, Demand and Key Producers, 2023-2029
The global Menopausal Medications market size is expected to reach $ 21990 million by 2029, rising at a market growth of 4.4% CAGR during the forecast period (2023-2029).
The driving force for the development of menopausal drugs mainly comes from the following aspects:
Growing demand for women’s health: As women’s demand for their own health grows, especially as their awareness and emphasis on menopausal syndrome increases, their demand for menopausal drugs is also increasing. These drugs can help relieve menopausal symptoms, such as hot flashes, insomnia, mood swings, etc., and improve quality of life.
Advances in medical technology: In recent years, the continuous advancement of medical technology has provided more means and options for menopausal drug treatment. For example, hormone replacement therapy (HRT) can effectively relieve menopausal symptoms and can also prevent some menopausal-related diseases, such as osteoporosis and cardiovascular disease. In addition, the development of new drugs such as phytoestrogens and natural progestins also provides more options for menopausal drug treatment.
Increased health awareness of consumers: As consumers’ health awareness continues to increase, they have put forward higher requirements for the safety, effectiveness and quality of drugs. Against this background, some new menopausal drugs, such as phytoestrogens and natural progestins, are favored by more and more consumers due to their smaller side effects, more natural and safer characteristics.
Adapt to changes in market demand: As the market changes, pharmaceutical companies are constantly launching new varieties that adapt to market demand. For example, some new menopausal drugs can not only relieve menopausal symptoms, but also have multiple functions such as preventing diseases and improving quality of life, adapting to the diverse needs of modern people for health.
Policy support: The government is also promoting the innovative development of the pharmaceutical industry, and some policies also provide support for the development of menopausal drugs. For example, the state encourages and supports pharmaceutical companies to carry out technological innovation and industrial upgrading, providing a good policy environment for the research, development and application of new drugs.
To sum up, the development drivers of menopausal drugs are multifaceted, including the growth of women’s health needs, advancements in medical technology, increased consumer health awareness, adaptation to changes in market demand, and policy support. These factors jointly promote the continuous innovation and development of menopausal drugs.
This report studies the global Menopausal Medications demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Menopausal Medications, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Menopausal Medications that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Menopausal Medications total market, 2018-2029, (USD Million)
Global Menopausal Medications total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Menopausal Medications total market, key domestic companies and share, (USD Million)
Global Menopausal Medications revenue by player and market share 2018-2023, (USD Million)
Global Menopausal Medications total market by Type, CAGR, 2018-2029, (USD Million)
Global Menopausal Medications total market by Sales Channel, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Menopausal Medications market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Novartis, Novo Nordisk, Pfizer, Allergan, Emcure Pharmaceuticals, Eli Lilly And Company, Bayer and Theramex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Menopausal Medications market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Sales Channel. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Menopausal Medications Market, By Region:
1. How big is the global Menopausal Medications market?
2. What is the demand of the global Menopausal Medications market?
3. What is the year over year growth of the global Menopausal Medications market?
4. What is the total value of the global Menopausal Medications market?
5. Who are the major players in the global Menopausal Medications market?
The driving force for the development of menopausal drugs mainly comes from the following aspects:
Growing demand for women’s health: As women’s demand for their own health grows, especially as their awareness and emphasis on menopausal syndrome increases, their demand for menopausal drugs is also increasing. These drugs can help relieve menopausal symptoms, such as hot flashes, insomnia, mood swings, etc., and improve quality of life.
Advances in medical technology: In recent years, the continuous advancement of medical technology has provided more means and options for menopausal drug treatment. For example, hormone replacement therapy (HRT) can effectively relieve menopausal symptoms and can also prevent some menopausal-related diseases, such as osteoporosis and cardiovascular disease. In addition, the development of new drugs such as phytoestrogens and natural progestins also provides more options for menopausal drug treatment.
Increased health awareness of consumers: As consumers’ health awareness continues to increase, they have put forward higher requirements for the safety, effectiveness and quality of drugs. Against this background, some new menopausal drugs, such as phytoestrogens and natural progestins, are favored by more and more consumers due to their smaller side effects, more natural and safer characteristics.
Adapt to changes in market demand: As the market changes, pharmaceutical companies are constantly launching new varieties that adapt to market demand. For example, some new menopausal drugs can not only relieve menopausal symptoms, but also have multiple functions such as preventing diseases and improving quality of life, adapting to the diverse needs of modern people for health.
Policy support: The government is also promoting the innovative development of the pharmaceutical industry, and some policies also provide support for the development of menopausal drugs. For example, the state encourages and supports pharmaceutical companies to carry out technological innovation and industrial upgrading, providing a good policy environment for the research, development and application of new drugs.
To sum up, the development drivers of menopausal drugs are multifaceted, including the growth of women’s health needs, advancements in medical technology, increased consumer health awareness, adaptation to changes in market demand, and policy support. These factors jointly promote the continuous innovation and development of menopausal drugs.
This report studies the global Menopausal Medications demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Menopausal Medications, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Menopausal Medications that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Menopausal Medications total market, 2018-2029, (USD Million)
Global Menopausal Medications total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Menopausal Medications total market, key domestic companies and share, (USD Million)
Global Menopausal Medications revenue by player and market share 2018-2023, (USD Million)
Global Menopausal Medications total market by Type, CAGR, 2018-2029, (USD Million)
Global Menopausal Medications total market by Sales Channel, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Menopausal Medications market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Novartis, Novo Nordisk, Pfizer, Allergan, Emcure Pharmaceuticals, Eli Lilly And Company, Bayer and Theramex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Menopausal Medications market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Sales Channel. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Menopausal Medications Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Hormone Drugs
- Chinese Proprietary Medicine
- Online Sales
- Offline Sales
- Merck
- Novartis
- Novo Nordisk
- Pfizer
- Allergan
- Emcure Pharmaceuticals
- Eli Lilly And Company
- Bayer
- Theramex
- AbbVie
- Assertio(Depomed)
- Hisamitsu Pharmaceutical
- Roche
- Xintian Pharmaceutical
- Jiangxi Yaodu Zhangshu Pharmaceutical
- Jinbao Pharmaceutical
- Tong Ren Tang
- Huaxi Pharmaceutical
1. How big is the global Menopausal Medications market?
2. What is the demand of the global Menopausal Medications market?
3. What is the year over year growth of the global Menopausal Medications market?
4. What is the total value of the global Menopausal Medications market?
5. Who are the major players in the global Menopausal Medications market?
1 SUPPLY SUMMARY
1.1 Menopausal Medications Introduction
1.2 World Menopausal Medications Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Menopausal Medications Total Market by Region (by Headquarter Location)
1.3.1 World Menopausal Medications Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Menopausal Medications Market Size (2018-2029)
1.3.3 China Menopausal Medications Market Size (2018-2029)
1.3.4 Europe Menopausal Medications Market Size (2018-2029)
1.3.5 Japan Menopausal Medications Market Size (2018-2029)
1.3.6 South Korea Menopausal Medications Market Size (2018-2029)
1.3.7 ASEAN Menopausal Medications Market Size (2018-2029)
1.3.8 India Menopausal Medications Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Menopausal Medications Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Menopausal Medications Major Market Trends
2 DEMAND SUMMARY
2.1 World Menopausal Medications Consumption Value (2018-2029)
2.2 World Menopausal Medications Consumption Value by Region
2.2.1 World Menopausal Medications Consumption Value by Region (2018-2023)
2.2.2 World Menopausal Medications Consumption Value Forecast by Region (2024-2029)
2.3 United States Menopausal Medications Consumption Value (2018-2029)
2.4 China Menopausal Medications Consumption Value (2018-2029)
2.5 Europe Menopausal Medications Consumption Value (2018-2029)
2.6 Japan Menopausal Medications Consumption Value (2018-2029)
2.7 South Korea Menopausal Medications Consumption Value (2018-2029)
2.8 ASEAN Menopausal Medications Consumption Value (2018-2029)
2.9 India Menopausal Medications Consumption Value (2018-2029)
3 WORLD MENOPAUSAL MEDICATIONS COMPANIES COMPETITIVE ANALYSIS
3.1 World Menopausal Medications Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Menopausal Medications Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Menopausal Medications in 2022
3.2.3 Global Concentration Ratios (CR8) for Menopausal Medications in 2022
3.3 Menopausal Medications Company Evaluation Quadrant
3.4 Menopausal Medications Market: Overall Company Footprint Analysis
3.4.1 Menopausal Medications Market: Region Footprint
3.4.2 Menopausal Medications Market: Company Product Type Footprint
3.4.3 Menopausal Medications Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Menopausal Medications Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Menopausal Medications Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Menopausal Medications Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Menopausal Medications Consumption Value Comparison
4.2.1 United States VS China: Menopausal Medications Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Menopausal Medications Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Menopausal Medications Companies and Market Share, 2018-2023
4.3.1 United States Based Menopausal Medications Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Menopausal Medications Revenue, (2018-2023)
4.4 China Based Companies Menopausal Medications Revenue and Market Share, 2018-2023
4.4.1 China Based Menopausal Medications Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Menopausal Medications Revenue, (2018-2023)
4.5 Rest of World Based Menopausal Medications Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Menopausal Medications Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Menopausal Medications Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Menopausal Medications Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Hormone Drugs
5.2.2 Chinese Proprietary Medicine
5.3 Market Segment by Type
5.3.1 World Menopausal Medications Market Size by Type (2018-2023)
5.3.2 World Menopausal Medications Market Size by Type (2024-2029)
5.3.3 World Menopausal Medications Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY SALES CHANNEL
6.1 World Menopausal Medications Market Size Overview by Sales Channel: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Sales Channel
6.2.1 Online Sales
6.2.2 Offline Sales
6.3 Market Segment by Sales Channel
6.3.1 World Menopausal Medications Market Size by Sales Channel (2018-2023)
6.3.2 World Menopausal Medications Market Size by Sales Channel (2024-2029)
6.3.3 World Menopausal Medications Market Size by Sales Channel (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Menopausal Medications Product and Services
7.1.4 Merck Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Menopausal Medications Product and Services
7.2.4 Novartis Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Novo Nordisk
7.3.1 Novo Nordisk Details
7.3.2 Novo Nordisk Major Business
7.3.3 Novo Nordisk Menopausal Medications Product and Services
7.3.4 Novo Nordisk Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Novo Nordisk Recent Developments/Updates
7.3.6 Novo Nordisk Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Menopausal Medications Product and Services
7.4.4 Pfizer Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Allergan
7.5.1 Allergan Details
7.5.2 Allergan Major Business
7.5.3 Allergan Menopausal Medications Product and Services
7.5.4 Allergan Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Allergan Recent Developments/Updates
7.5.6 Allergan Competitive Strengths & Weaknesses
7.6 Emcure Pharmaceuticals
7.6.1 Emcure Pharmaceuticals Details
7.6.2 Emcure Pharmaceuticals Major Business
7.6.3 Emcure Pharmaceuticals Menopausal Medications Product and Services
7.6.4 Emcure Pharmaceuticals Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Emcure Pharmaceuticals Recent Developments/Updates
7.6.6 Emcure Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Eli Lilly And Company
7.7.1 Eli Lilly And Company Details
7.7.2 Eli Lilly And Company Major Business
7.7.3 Eli Lilly And Company Menopausal Medications Product and Services
7.7.4 Eli Lilly And Company Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Eli Lilly And Company Recent Developments/Updates
7.7.6 Eli Lilly And Company Competitive Strengths & Weaknesses
7.8 Bayer
7.8.1 Bayer Details
7.8.2 Bayer Major Business
7.8.3 Bayer Menopausal Medications Product and Services
7.8.4 Bayer Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Bayer Recent Developments/Updates
7.8.6 Bayer Competitive Strengths & Weaknesses
7.9 Theramex
7.9.1 Theramex Details
7.9.2 Theramex Major Business
7.9.3 Theramex Menopausal Medications Product and Services
7.9.4 Theramex Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Theramex Recent Developments/Updates
7.9.6 Theramex Competitive Strengths & Weaknesses
7.10 AbbVie
7.10.1 AbbVie Details
7.10.2 AbbVie Major Business
7.10.3 AbbVie Menopausal Medications Product and Services
7.10.4 AbbVie Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 AbbVie Recent Developments/Updates
7.10.6 AbbVie Competitive Strengths & Weaknesses
7.11 Assertio(Depomed)
7.11.1 Assertio(Depomed) Details
7.11.2 Assertio(Depomed) Major Business
7.11.3 Assertio(Depomed) Menopausal Medications Product and Services
7.11.4 Assertio(Depomed) Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Assertio(Depomed) Recent Developments/Updates
7.11.6 Assertio(Depomed) Competitive Strengths & Weaknesses
7.12 Hisamitsu Pharmaceutical
7.12.1 Hisamitsu Pharmaceutical Details
7.12.2 Hisamitsu Pharmaceutical Major Business
7.12.3 Hisamitsu Pharmaceutical Menopausal Medications Product and Services
7.12.4 Hisamitsu Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Hisamitsu Pharmaceutical Recent Developments/Updates
7.12.6 Hisamitsu Pharmaceutical Competitive Strengths & Weaknesses
7.13 Roche
7.13.1 Roche Details
7.13.2 Roche Major Business
7.13.3 Roche Menopausal Medications Product and Services
7.13.4 Roche Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Roche Recent Developments/Updates
7.13.6 Roche Competitive Strengths & Weaknesses
7.14 Xintian Pharmaceutical
7.14.1 Xintian Pharmaceutical Details
7.14.2 Xintian Pharmaceutical Major Business
7.14.3 Xintian Pharmaceutical Menopausal Medications Product and Services
7.14.4 Xintian Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Xintian Pharmaceutical Recent Developments/Updates
7.14.6 Xintian Pharmaceutical Competitive Strengths & Weaknesses
7.15 Jiangxi Yaodu Zhangshu Pharmaceutical
7.15.1 Jiangxi Yaodu Zhangshu Pharmaceutical Details
7.15.2 Jiangxi Yaodu Zhangshu Pharmaceutical Major Business
7.15.3 Jiangxi Yaodu Zhangshu Pharmaceutical Menopausal Medications Product and Services
7.15.4 Jiangxi Yaodu Zhangshu Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Jiangxi Yaodu Zhangshu Pharmaceutical Recent Developments/Updates
7.15.6 Jiangxi Yaodu Zhangshu Pharmaceutical Competitive Strengths & Weaknesses
7.16 Jinbao Pharmaceutical
7.16.1 Jinbao Pharmaceutical Details
7.16.2 Jinbao Pharmaceutical Major Business
7.16.3 Jinbao Pharmaceutical Menopausal Medications Product and Services
7.16.4 Jinbao Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Jinbao Pharmaceutical Recent Developments/Updates
7.16.6 Jinbao Pharmaceutical Competitive Strengths & Weaknesses
7.17 Tong Ren Tang
7.17.1 Tong Ren Tang Details
7.17.2 Tong Ren Tang Major Business
7.17.3 Tong Ren Tang Menopausal Medications Product and Services
7.17.4 Tong Ren Tang Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Tong Ren Tang Recent Developments/Updates
7.17.6 Tong Ren Tang Competitive Strengths & Weaknesses
7.18 Huaxi Pharmaceutical
7.18.1 Huaxi Pharmaceutical Details
7.18.2 Huaxi Pharmaceutical Major Business
7.18.3 Huaxi Pharmaceutical Menopausal Medications Product and Services
7.18.4 Huaxi Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Huaxi Pharmaceutical Recent Developments/Updates
7.18.6 Huaxi Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Menopausal Medications Industry Chain
8.2 Menopausal Medications Upstream Analysis
8.3 Menopausal Medications Midstream Analysis
8.4 Menopausal Medications Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Menopausal Medications Introduction
1.2 World Menopausal Medications Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Menopausal Medications Total Market by Region (by Headquarter Location)
1.3.1 World Menopausal Medications Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Menopausal Medications Market Size (2018-2029)
1.3.3 China Menopausal Medications Market Size (2018-2029)
1.3.4 Europe Menopausal Medications Market Size (2018-2029)
1.3.5 Japan Menopausal Medications Market Size (2018-2029)
1.3.6 South Korea Menopausal Medications Market Size (2018-2029)
1.3.7 ASEAN Menopausal Medications Market Size (2018-2029)
1.3.8 India Menopausal Medications Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Menopausal Medications Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Menopausal Medications Major Market Trends
2 DEMAND SUMMARY
2.1 World Menopausal Medications Consumption Value (2018-2029)
2.2 World Menopausal Medications Consumption Value by Region
2.2.1 World Menopausal Medications Consumption Value by Region (2018-2023)
2.2.2 World Menopausal Medications Consumption Value Forecast by Region (2024-2029)
2.3 United States Menopausal Medications Consumption Value (2018-2029)
2.4 China Menopausal Medications Consumption Value (2018-2029)
2.5 Europe Menopausal Medications Consumption Value (2018-2029)
2.6 Japan Menopausal Medications Consumption Value (2018-2029)
2.7 South Korea Menopausal Medications Consumption Value (2018-2029)
2.8 ASEAN Menopausal Medications Consumption Value (2018-2029)
2.9 India Menopausal Medications Consumption Value (2018-2029)
3 WORLD MENOPAUSAL MEDICATIONS COMPANIES COMPETITIVE ANALYSIS
3.1 World Menopausal Medications Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Menopausal Medications Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Menopausal Medications in 2022
3.2.3 Global Concentration Ratios (CR8) for Menopausal Medications in 2022
3.3 Menopausal Medications Company Evaluation Quadrant
3.4 Menopausal Medications Market: Overall Company Footprint Analysis
3.4.1 Menopausal Medications Market: Region Footprint
3.4.2 Menopausal Medications Market: Company Product Type Footprint
3.4.3 Menopausal Medications Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Menopausal Medications Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Menopausal Medications Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Menopausal Medications Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Menopausal Medications Consumption Value Comparison
4.2.1 United States VS China: Menopausal Medications Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Menopausal Medications Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Menopausal Medications Companies and Market Share, 2018-2023
4.3.1 United States Based Menopausal Medications Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Menopausal Medications Revenue, (2018-2023)
4.4 China Based Companies Menopausal Medications Revenue and Market Share, 2018-2023
4.4.1 China Based Menopausal Medications Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Menopausal Medications Revenue, (2018-2023)
4.5 Rest of World Based Menopausal Medications Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Menopausal Medications Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Menopausal Medications Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Menopausal Medications Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Hormone Drugs
5.2.2 Chinese Proprietary Medicine
5.3 Market Segment by Type
5.3.1 World Menopausal Medications Market Size by Type (2018-2023)
5.3.2 World Menopausal Medications Market Size by Type (2024-2029)
5.3.3 World Menopausal Medications Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY SALES CHANNEL
6.1 World Menopausal Medications Market Size Overview by Sales Channel: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Sales Channel
6.2.1 Online Sales
6.2.2 Offline Sales
6.3 Market Segment by Sales Channel
6.3.1 World Menopausal Medications Market Size by Sales Channel (2018-2023)
6.3.2 World Menopausal Medications Market Size by Sales Channel (2024-2029)
6.3.3 World Menopausal Medications Market Size by Sales Channel (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Menopausal Medications Product and Services
7.1.4 Merck Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Menopausal Medications Product and Services
7.2.4 Novartis Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Novo Nordisk
7.3.1 Novo Nordisk Details
7.3.2 Novo Nordisk Major Business
7.3.3 Novo Nordisk Menopausal Medications Product and Services
7.3.4 Novo Nordisk Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Novo Nordisk Recent Developments/Updates
7.3.6 Novo Nordisk Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Menopausal Medications Product and Services
7.4.4 Pfizer Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Allergan
7.5.1 Allergan Details
7.5.2 Allergan Major Business
7.5.3 Allergan Menopausal Medications Product and Services
7.5.4 Allergan Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Allergan Recent Developments/Updates
7.5.6 Allergan Competitive Strengths & Weaknesses
7.6 Emcure Pharmaceuticals
7.6.1 Emcure Pharmaceuticals Details
7.6.2 Emcure Pharmaceuticals Major Business
7.6.3 Emcure Pharmaceuticals Menopausal Medications Product and Services
7.6.4 Emcure Pharmaceuticals Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Emcure Pharmaceuticals Recent Developments/Updates
7.6.6 Emcure Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Eli Lilly And Company
7.7.1 Eli Lilly And Company Details
7.7.2 Eli Lilly And Company Major Business
7.7.3 Eli Lilly And Company Menopausal Medications Product and Services
7.7.4 Eli Lilly And Company Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Eli Lilly And Company Recent Developments/Updates
7.7.6 Eli Lilly And Company Competitive Strengths & Weaknesses
7.8 Bayer
7.8.1 Bayer Details
7.8.2 Bayer Major Business
7.8.3 Bayer Menopausal Medications Product and Services
7.8.4 Bayer Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Bayer Recent Developments/Updates
7.8.6 Bayer Competitive Strengths & Weaknesses
7.9 Theramex
7.9.1 Theramex Details
7.9.2 Theramex Major Business
7.9.3 Theramex Menopausal Medications Product and Services
7.9.4 Theramex Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Theramex Recent Developments/Updates
7.9.6 Theramex Competitive Strengths & Weaknesses
7.10 AbbVie
7.10.1 AbbVie Details
7.10.2 AbbVie Major Business
7.10.3 AbbVie Menopausal Medications Product and Services
7.10.4 AbbVie Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 AbbVie Recent Developments/Updates
7.10.6 AbbVie Competitive Strengths & Weaknesses
7.11 Assertio(Depomed)
7.11.1 Assertio(Depomed) Details
7.11.2 Assertio(Depomed) Major Business
7.11.3 Assertio(Depomed) Menopausal Medications Product and Services
7.11.4 Assertio(Depomed) Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Assertio(Depomed) Recent Developments/Updates
7.11.6 Assertio(Depomed) Competitive Strengths & Weaknesses
7.12 Hisamitsu Pharmaceutical
7.12.1 Hisamitsu Pharmaceutical Details
7.12.2 Hisamitsu Pharmaceutical Major Business
7.12.3 Hisamitsu Pharmaceutical Menopausal Medications Product and Services
7.12.4 Hisamitsu Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Hisamitsu Pharmaceutical Recent Developments/Updates
7.12.6 Hisamitsu Pharmaceutical Competitive Strengths & Weaknesses
7.13 Roche
7.13.1 Roche Details
7.13.2 Roche Major Business
7.13.3 Roche Menopausal Medications Product and Services
7.13.4 Roche Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Roche Recent Developments/Updates
7.13.6 Roche Competitive Strengths & Weaknesses
7.14 Xintian Pharmaceutical
7.14.1 Xintian Pharmaceutical Details
7.14.2 Xintian Pharmaceutical Major Business
7.14.3 Xintian Pharmaceutical Menopausal Medications Product and Services
7.14.4 Xintian Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Xintian Pharmaceutical Recent Developments/Updates
7.14.6 Xintian Pharmaceutical Competitive Strengths & Weaknesses
7.15 Jiangxi Yaodu Zhangshu Pharmaceutical
7.15.1 Jiangxi Yaodu Zhangshu Pharmaceutical Details
7.15.2 Jiangxi Yaodu Zhangshu Pharmaceutical Major Business
7.15.3 Jiangxi Yaodu Zhangshu Pharmaceutical Menopausal Medications Product and Services
7.15.4 Jiangxi Yaodu Zhangshu Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Jiangxi Yaodu Zhangshu Pharmaceutical Recent Developments/Updates
7.15.6 Jiangxi Yaodu Zhangshu Pharmaceutical Competitive Strengths & Weaknesses
7.16 Jinbao Pharmaceutical
7.16.1 Jinbao Pharmaceutical Details
7.16.2 Jinbao Pharmaceutical Major Business
7.16.3 Jinbao Pharmaceutical Menopausal Medications Product and Services
7.16.4 Jinbao Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Jinbao Pharmaceutical Recent Developments/Updates
7.16.6 Jinbao Pharmaceutical Competitive Strengths & Weaknesses
7.17 Tong Ren Tang
7.17.1 Tong Ren Tang Details
7.17.2 Tong Ren Tang Major Business
7.17.3 Tong Ren Tang Menopausal Medications Product and Services
7.17.4 Tong Ren Tang Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Tong Ren Tang Recent Developments/Updates
7.17.6 Tong Ren Tang Competitive Strengths & Weaknesses
7.18 Huaxi Pharmaceutical
7.18.1 Huaxi Pharmaceutical Details
7.18.2 Huaxi Pharmaceutical Major Business
7.18.3 Huaxi Pharmaceutical Menopausal Medications Product and Services
7.18.4 Huaxi Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Huaxi Pharmaceutical Recent Developments/Updates
7.18.6 Huaxi Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Menopausal Medications Industry Chain
8.2 Menopausal Medications Upstream Analysis
8.3 Menopausal Medications Midstream Analysis
8.4 Menopausal Medications Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Menopausal Medications Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Menopausal Medications Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Menopausal Medications Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Menopausal Medications Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Menopausal Medications Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Menopausal Medications Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Menopausal Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Menopausal Medications Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Menopausal Medications Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Menopausal Medications Players in 2022
Table 12. World Menopausal Medications Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Menopausal Medications Company Evaluation Quadrant
Table 14. Head Office of Key Menopausal Medications Player
Table 15. Menopausal Medications Market: Company Product Type Footprint
Table 16. Menopausal Medications Market: Company Product Application Footprint
Table 17. Menopausal Medications Mergers & Acquisitions Activity
Table 18. United States VS China Menopausal Medications Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Menopausal Medications Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Menopausal Medications Companies, Headquarters (States, Country)
Table 21. United States Based Companies Menopausal Medications Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Menopausal Medications Revenue Market Share (2018-2023)
Table 23. China Based Menopausal Medications Companies, Headquarters (Province, Country)
Table 24. China Based Companies Menopausal Medications Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Menopausal Medications Revenue Market Share (2018-2023)
Table 26. Rest of World Based Menopausal Medications Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Menopausal Medications Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Menopausal Medications Revenue Market Share (2018-2023)
Table 29. World Menopausal Medications Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Menopausal Medications Market Size by Type (2018-2023) & (USD Million)
Table 31. World Menopausal Medications Market Size by Type (2024-2029) & (USD Million)
Table 32. World Menopausal Medications Market Size by Sales Channel, (USD Million), 2018 & 2022 & 2029
Table 33. World Menopausal Medications Market Size by Sales Channel (2018-2023) & (USD Million)
Table 34. World Menopausal Medications Market Size by Sales Channel (2024-2029) & (USD Million)
Table 35. Merck Basic Information, Area Served and Competitors
Table 36. Merck Major Business
Table 37. Merck Menopausal Medications Product and Services
Table 38. Merck Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Merck Recent Developments/Updates
Table 40. Merck Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Area Served and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Menopausal Medications Product and Services
Table 44. Novartis Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Novo Nordisk Basic Information, Area Served and Competitors
Table 48. Novo Nordisk Major Business
Table 49. Novo Nordisk Menopausal Medications Product and Services
Table 50. Novo Nordisk Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Novo Nordisk Recent Developments/Updates
Table 52. Novo Nordisk Competitive Strengths & Weaknesses
Table 53. Pfizer Basic Information, Area Served and Competitors
Table 54. Pfizer Major Business
Table 55. Pfizer Menopausal Medications Product and Services
Table 56. Pfizer Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Pfizer Recent Developments/Updates
Table 58. Pfizer Competitive Strengths & Weaknesses
Table 59. Allergan Basic Information, Area Served and Competitors
Table 60. Allergan Major Business
Table 61. Allergan Menopausal Medications Product and Services
Table 62. Allergan Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Allergan Recent Developments/Updates
Table 64. Allergan Competitive Strengths & Weaknesses
Table 65. Emcure Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. Emcure Pharmaceuticals Major Business
Table 67. Emcure Pharmaceuticals Menopausal Medications Product and Services
Table 68. Emcure Pharmaceuticals Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Emcure Pharmaceuticals Recent Developments/Updates
Table 70. Emcure Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Eli Lilly And Company Basic Information, Area Served and Competitors
Table 72. Eli Lilly And Company Major Business
Table 73. Eli Lilly And Company Menopausal Medications Product and Services
Table 74. Eli Lilly And Company Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Eli Lilly And Company Recent Developments/Updates
Table 76. Eli Lilly And Company Competitive Strengths & Weaknesses
Table 77. Bayer Basic Information, Area Served and Competitors
Table 78. Bayer Major Business
Table 79. Bayer Menopausal Medications Product and Services
Table 80. Bayer Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Bayer Recent Developments/Updates
Table 82. Bayer Competitive Strengths & Weaknesses
Table 83. Theramex Basic Information, Area Served and Competitors
Table 84. Theramex Major Business
Table 85. Theramex Menopausal Medications Product and Services
Table 86. Theramex Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Theramex Recent Developments/Updates
Table 88. Theramex Competitive Strengths & Weaknesses
Table 89. AbbVie Basic Information, Area Served and Competitors
Table 90. AbbVie Major Business
Table 91. AbbVie Menopausal Medications Product and Services
Table 92. AbbVie Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. AbbVie Recent Developments/Updates
Table 94. AbbVie Competitive Strengths & Weaknesses
Table 95. Assertio(Depomed) Basic Information, Area Served and Competitors
Table 96. Assertio(Depomed) Major Business
Table 97. Assertio(Depomed) Menopausal Medications Product and Services
Table 98. Assertio(Depomed) Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Assertio(Depomed) Recent Developments/Updates
Table 100. Assertio(Depomed) Competitive Strengths & Weaknesses
Table 101. Hisamitsu Pharmaceutical Basic Information, Area Served and Competitors
Table 102. Hisamitsu Pharmaceutical Major Business
Table 103. Hisamitsu Pharmaceutical Menopausal Medications Product and Services
Table 104. Hisamitsu Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 106. Hisamitsu Pharmaceutical Competitive Strengths & Weaknesses
Table 107. Roche Basic Information, Area Served and Competitors
Table 108. Roche Major Business
Table 109. Roche Menopausal Medications Product and Services
Table 110. Roche Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Roche Recent Developments/Updates
Table 112. Roche Competitive Strengths & Weaknesses
Table 113. Xintian Pharmaceutical Basic Information, Area Served and Competitors
Table 114. Xintian Pharmaceutical Major Business
Table 115. Xintian Pharmaceutical Menopausal Medications Product and Services
Table 116. Xintian Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Xintian Pharmaceutical Recent Developments/Updates
Table 118. Xintian Pharmaceutical Competitive Strengths & Weaknesses
Table 119. Jiangxi Yaodu Zhangshu Pharmaceutical Basic Information, Area Served and Competitors
Table 120. Jiangxi Yaodu Zhangshu Pharmaceutical Major Business
Table 121. Jiangxi Yaodu Zhangshu Pharmaceutical Menopausal Medications Product and Services
Table 122. Jiangxi Yaodu Zhangshu Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Jiangxi Yaodu Zhangshu Pharmaceutical Recent Developments/Updates
Table 124. Jiangxi Yaodu Zhangshu Pharmaceutical Competitive Strengths & Weaknesses
Table 125. Jinbao Pharmaceutical Basic Information, Area Served and Competitors
Table 126. Jinbao Pharmaceutical Major Business
Table 127. Jinbao Pharmaceutical Menopausal Medications Product and Services
Table 128. Jinbao Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Jinbao Pharmaceutical Recent Developments/Updates
Table 130. Jinbao Pharmaceutical Competitive Strengths & Weaknesses
Table 131. Tong Ren Tang Basic Information, Area Served and Competitors
Table 132. Tong Ren Tang Major Business
Table 133. Tong Ren Tang Menopausal Medications Product and Services
Table 134. Tong Ren Tang Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Tong Ren Tang Recent Developments/Updates
Table 136. Huaxi Pharmaceutical Basic Information, Area Served and Competitors
Table 137. Huaxi Pharmaceutical Major Business
Table 138. Huaxi Pharmaceutical Menopausal Medications Product and Services
Table 139. Huaxi Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Menopausal Medications Upstream (Raw Materials)
Table 141. Menopausal Medications Typical Customers
LIST OF FIGURE
Figure 1. Menopausal Medications Picture
Figure 2. World Menopausal Medications Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Menopausal Medications Total Market Size (2018-2029) & (USD Million)
Figure 4. World Menopausal Medications Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Menopausal Medications Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 13. Menopausal Medications Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 16. World Menopausal Medications Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 18. China Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 23. India Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Menopausal Medications by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Menopausal Medications Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Menopausal Medications Markets in 2022
Figure 27. United States VS China: Menopausal Medications Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Menopausal Medications Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Menopausal Medications Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Menopausal Medications Market Size Market Share by Type in 2022
Figure 31. Hormone Drugs
Figure 32. Chinese Proprietary Medicine
Figure 33. World Menopausal Medications Market Size Market Share by Type (2018-2029)
Figure 34. World Menopausal Medications Market Size by Sales Channel, (USD Million), 2018 & 2022 & 2029
Figure 35. World Menopausal Medications Market Size Market Share by Sales Channel in 2022
Figure 36. Online Sales
Figure 37. Offline Sales
Figure 38. Menopausal Medications Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
Table 1. World Menopausal Medications Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Menopausal Medications Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Menopausal Medications Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Menopausal Medications Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Menopausal Medications Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Menopausal Medications Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Menopausal Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Menopausal Medications Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Menopausal Medications Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Menopausal Medications Players in 2022
Table 12. World Menopausal Medications Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Menopausal Medications Company Evaluation Quadrant
Table 14. Head Office of Key Menopausal Medications Player
Table 15. Menopausal Medications Market: Company Product Type Footprint
Table 16. Menopausal Medications Market: Company Product Application Footprint
Table 17. Menopausal Medications Mergers & Acquisitions Activity
Table 18. United States VS China Menopausal Medications Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Menopausal Medications Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Menopausal Medications Companies, Headquarters (States, Country)
Table 21. United States Based Companies Menopausal Medications Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Menopausal Medications Revenue Market Share (2018-2023)
Table 23. China Based Menopausal Medications Companies, Headquarters (Province, Country)
Table 24. China Based Companies Menopausal Medications Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Menopausal Medications Revenue Market Share (2018-2023)
Table 26. Rest of World Based Menopausal Medications Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Menopausal Medications Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Menopausal Medications Revenue Market Share (2018-2023)
Table 29. World Menopausal Medications Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Menopausal Medications Market Size by Type (2018-2023) & (USD Million)
Table 31. World Menopausal Medications Market Size by Type (2024-2029) & (USD Million)
Table 32. World Menopausal Medications Market Size by Sales Channel, (USD Million), 2018 & 2022 & 2029
Table 33. World Menopausal Medications Market Size by Sales Channel (2018-2023) & (USD Million)
Table 34. World Menopausal Medications Market Size by Sales Channel (2024-2029) & (USD Million)
Table 35. Merck Basic Information, Area Served and Competitors
Table 36. Merck Major Business
Table 37. Merck Menopausal Medications Product and Services
Table 38. Merck Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Merck Recent Developments/Updates
Table 40. Merck Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Area Served and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Menopausal Medications Product and Services
Table 44. Novartis Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Novo Nordisk Basic Information, Area Served and Competitors
Table 48. Novo Nordisk Major Business
Table 49. Novo Nordisk Menopausal Medications Product and Services
Table 50. Novo Nordisk Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Novo Nordisk Recent Developments/Updates
Table 52. Novo Nordisk Competitive Strengths & Weaknesses
Table 53. Pfizer Basic Information, Area Served and Competitors
Table 54. Pfizer Major Business
Table 55. Pfizer Menopausal Medications Product and Services
Table 56. Pfizer Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Pfizer Recent Developments/Updates
Table 58. Pfizer Competitive Strengths & Weaknesses
Table 59. Allergan Basic Information, Area Served and Competitors
Table 60. Allergan Major Business
Table 61. Allergan Menopausal Medications Product and Services
Table 62. Allergan Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Allergan Recent Developments/Updates
Table 64. Allergan Competitive Strengths & Weaknesses
Table 65. Emcure Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. Emcure Pharmaceuticals Major Business
Table 67. Emcure Pharmaceuticals Menopausal Medications Product and Services
Table 68. Emcure Pharmaceuticals Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Emcure Pharmaceuticals Recent Developments/Updates
Table 70. Emcure Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Eli Lilly And Company Basic Information, Area Served and Competitors
Table 72. Eli Lilly And Company Major Business
Table 73. Eli Lilly And Company Menopausal Medications Product and Services
Table 74. Eli Lilly And Company Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Eli Lilly And Company Recent Developments/Updates
Table 76. Eli Lilly And Company Competitive Strengths & Weaknesses
Table 77. Bayer Basic Information, Area Served and Competitors
Table 78. Bayer Major Business
Table 79. Bayer Menopausal Medications Product and Services
Table 80. Bayer Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Bayer Recent Developments/Updates
Table 82. Bayer Competitive Strengths & Weaknesses
Table 83. Theramex Basic Information, Area Served and Competitors
Table 84. Theramex Major Business
Table 85. Theramex Menopausal Medications Product and Services
Table 86. Theramex Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Theramex Recent Developments/Updates
Table 88. Theramex Competitive Strengths & Weaknesses
Table 89. AbbVie Basic Information, Area Served and Competitors
Table 90. AbbVie Major Business
Table 91. AbbVie Menopausal Medications Product and Services
Table 92. AbbVie Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. AbbVie Recent Developments/Updates
Table 94. AbbVie Competitive Strengths & Weaknesses
Table 95. Assertio(Depomed) Basic Information, Area Served and Competitors
Table 96. Assertio(Depomed) Major Business
Table 97. Assertio(Depomed) Menopausal Medications Product and Services
Table 98. Assertio(Depomed) Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Assertio(Depomed) Recent Developments/Updates
Table 100. Assertio(Depomed) Competitive Strengths & Weaknesses
Table 101. Hisamitsu Pharmaceutical Basic Information, Area Served and Competitors
Table 102. Hisamitsu Pharmaceutical Major Business
Table 103. Hisamitsu Pharmaceutical Menopausal Medications Product and Services
Table 104. Hisamitsu Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 106. Hisamitsu Pharmaceutical Competitive Strengths & Weaknesses
Table 107. Roche Basic Information, Area Served and Competitors
Table 108. Roche Major Business
Table 109. Roche Menopausal Medications Product and Services
Table 110. Roche Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Roche Recent Developments/Updates
Table 112. Roche Competitive Strengths & Weaknesses
Table 113. Xintian Pharmaceutical Basic Information, Area Served and Competitors
Table 114. Xintian Pharmaceutical Major Business
Table 115. Xintian Pharmaceutical Menopausal Medications Product and Services
Table 116. Xintian Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Xintian Pharmaceutical Recent Developments/Updates
Table 118. Xintian Pharmaceutical Competitive Strengths & Weaknesses
Table 119. Jiangxi Yaodu Zhangshu Pharmaceutical Basic Information, Area Served and Competitors
Table 120. Jiangxi Yaodu Zhangshu Pharmaceutical Major Business
Table 121. Jiangxi Yaodu Zhangshu Pharmaceutical Menopausal Medications Product and Services
Table 122. Jiangxi Yaodu Zhangshu Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Jiangxi Yaodu Zhangshu Pharmaceutical Recent Developments/Updates
Table 124. Jiangxi Yaodu Zhangshu Pharmaceutical Competitive Strengths & Weaknesses
Table 125. Jinbao Pharmaceutical Basic Information, Area Served and Competitors
Table 126. Jinbao Pharmaceutical Major Business
Table 127. Jinbao Pharmaceutical Menopausal Medications Product and Services
Table 128. Jinbao Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Jinbao Pharmaceutical Recent Developments/Updates
Table 130. Jinbao Pharmaceutical Competitive Strengths & Weaknesses
Table 131. Tong Ren Tang Basic Information, Area Served and Competitors
Table 132. Tong Ren Tang Major Business
Table 133. Tong Ren Tang Menopausal Medications Product and Services
Table 134. Tong Ren Tang Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Tong Ren Tang Recent Developments/Updates
Table 136. Huaxi Pharmaceutical Basic Information, Area Served and Competitors
Table 137. Huaxi Pharmaceutical Major Business
Table 138. Huaxi Pharmaceutical Menopausal Medications Product and Services
Table 139. Huaxi Pharmaceutical Menopausal Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Menopausal Medications Upstream (Raw Materials)
Table 141. Menopausal Medications Typical Customers
LIST OF FIGURE
Figure 1. Menopausal Medications Picture
Figure 2. World Menopausal Medications Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Menopausal Medications Total Market Size (2018-2029) & (USD Million)
Figure 4. World Menopausal Medications Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Menopausal Medications Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Menopausal Medications Revenue (2018-2029) & (USD Million)
Figure 13. Menopausal Medications Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 16. World Menopausal Medications Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 18. China Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 23. India Menopausal Medications Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Menopausal Medications by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Menopausal Medications Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Menopausal Medications Markets in 2022
Figure 27. United States VS China: Menopausal Medications Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Menopausal Medications Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Menopausal Medications Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Menopausal Medications Market Size Market Share by Type in 2022
Figure 31. Hormone Drugs
Figure 32. Chinese Proprietary Medicine
Figure 33. World Menopausal Medications Market Size Market Share by Type (2018-2029)
Figure 34. World Menopausal Medications Market Size by Sales Channel, (USD Million), 2018 & 2022 & 2029
Figure 35. World Menopausal Medications Market Size Market Share by Sales Channel in 2022
Figure 36. Online Sales
Figure 37. Offline Sales
Figure 38. Menopausal Medications Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
